Robbinsville, New Jersey March 6, 2020 — The DCAT organization has been following the situation around COVID-19 very closely. While we recognize and appreciate how important this event is to our member companies, out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
We recognize the challenges this may cause, and we apologize for the inconvenience; however, it is our responsibility to prioritize the health and safety of our member companies, attendees, employees and all of those who help with this week-long event. The cancellation is consistent with the values of the DCAT organization and the member companies it serves.
We would like to thank all of our member companies, volunteers, sponsors and others for your patience and understanding. We look forward to seeing our global community of member companies for DCAT Week 2021, March 22-25 in New York City.
-The DCAT Board of Directors
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing. With over 400 corporate members, DCAT is headquartered in Robbinsville, New Jersey.
DCAT Sr. Communications & Technology Specialist